Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients

Cristina Canzi, Felicia Zito, Franco Voltini, Eugenio Reschini, Paolo Gerundini

Research output: Contribution to journalArticle

Abstract

The aim of this study was to verify the capability of an MIRD formula-based dosimetric method to predict radioiodine kinetics (fraction of administered iodine transferred to the thyroid, U0, and effective clearance rate, λeff) and absorbed dose after oral therapeutic 131I administration. The method is based on 123I intravenous administration and five subsequent gamma camera measured uptake values determined separately on different structures within the thyroid. Another dosimetric method based on only the 123I 24-h uptake and a fixed λeff value was also considered. Eighty-nine hyperthyroid patients (10 with Graves' disease and 79 with autonomously functioning nodules) were studied and 132 thyroidal structures were evaluated. The mean time interval between dosimetry and therapy was 20±10d. Uptake values were measured at 2, 4, 24, 48, and 120 h during dosimetry and at 2, 4, 24, 48, 96, and 168 h during therapy. The value 0.125d-1 was chosen in the fixed-λeff method. The planned doses to the target ranged from 120 to 250 Gy depending on the type and severity of hyperthyroidism. The following significant correlations between therapeutic and dosimetric parameters were found: U0ther=0.88U0dos (r=0.97, peffther =1.01λeffdos (r=0.85, pestimated=0.85Dplanned (r=0.88, p0ther and U0dos ranged from -44 to 32% and between λeffther and λeffdos from -32 to 48%. U0ther was lower than U0dos in 74% of cases: this can be explained by the self-stunning effect of 131I therapeutic activity that produced a dose of about 20 Gy with a maximum dose rate of 0.6 Gy/h over the initial 24-48 h. The differences, ΔD, between the estimated and the planned doses ranged from -42% (-87 Gy) to 32% (59 Gy); in 73% of cases the difference was within ±35 Gy. Greater discrepancies were found with the fixed-λeff method, in which ΔD ranged from -69 to 95% (-202 to 88 Gy, respectively). In hyperthyroid patients, the five uptake value dosimetric method is able to predict with a good agreement the radioiodine kinetics and the dose after the therapeutic administration in about 73% of the analyzed thyroid structures. The fixed-λeff method is less reliable.

Original languageEnglish
Pages (from-to)2860-2867
Number of pages8
JournalMedical Physics
Volume33
Issue number8
DOIs
Publication statusPublished - 2006

Fingerprint

Hyperthyroidism
Thyroid Gland
Therapeutics
Gamma Cameras
Graves Disease
Therapeutic Uses
Iodine
Intravenous Administration

Keywords

  • Dosimetry and therapy comparison
  • Hyperthyroidism
  • Radioiodine treatment

ASJC Scopus subject areas

  • Biophysics

Cite this

Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients. / Canzi, Cristina; Zito, Felicia; Voltini, Franco; Reschini, Eugenio; Gerundini, Paolo.

In: Medical Physics, Vol. 33, No. 8, 2006, p. 2860-2867.

Research output: Contribution to journalArticle

Canzi, Cristina ; Zito, Felicia ; Voltini, Franco ; Reschini, Eugenio ; Gerundini, Paolo. / Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients. In: Medical Physics. 2006 ; Vol. 33, No. 8. pp. 2860-2867.
@article{764083af5b4a410cb2f04291e6b6dcd8,
title = "Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients",
abstract = "The aim of this study was to verify the capability of an MIRD formula-based dosimetric method to predict radioiodine kinetics (fraction of administered iodine transferred to the thyroid, U0, and effective clearance rate, λeff) and absorbed dose after oral therapeutic 131I administration. The method is based on 123I intravenous administration and five subsequent gamma camera measured uptake values determined separately on different structures within the thyroid. Another dosimetric method based on only the 123I 24-h uptake and a fixed λeff value was also considered. Eighty-nine hyperthyroid patients (10 with Graves' disease and 79 with autonomously functioning nodules) were studied and 132 thyroidal structures were evaluated. The mean time interval between dosimetry and therapy was 20±10d. Uptake values were measured at 2, 4, 24, 48, and 120 h during dosimetry and at 2, 4, 24, 48, 96, and 168 h during therapy. The value 0.125d-1 was chosen in the fixed-λeff method. The planned doses to the target ranged from 120 to 250 Gy depending on the type and severity of hyperthyroidism. The following significant correlations between therapeutic and dosimetric parameters were found: U0ther=0.88U0dos (r=0.97, peffther =1.01λeffdos (r=0.85, pestimated=0.85Dplanned (r=0.88, p0ther and U0dos ranged from -44 to 32{\%} and between λeffther and λeffdos from -32 to 48{\%}. U0ther was lower than U0dos in 74{\%} of cases: this can be explained by the self-stunning effect of 131I therapeutic activity that produced a dose of about 20 Gy with a maximum dose rate of 0.6 Gy/h over the initial 24-48 h. The differences, ΔD, between the estimated and the planned doses ranged from -42{\%} (-87 Gy) to 32{\%} (59 Gy); in 73{\%} of cases the difference was within ±35 Gy. Greater discrepancies were found with the fixed-λeff method, in which ΔD ranged from -69 to 95{\%} (-202 to 88 Gy, respectively). In hyperthyroid patients, the five uptake value dosimetric method is able to predict with a good agreement the radioiodine kinetics and the dose after the therapeutic administration in about 73{\%} of the analyzed thyroid structures. The fixed-λeff method is less reliable.",
keywords = "Dosimetry and therapy comparison, Hyperthyroidism, Radioiodine treatment",
author = "Cristina Canzi and Felicia Zito and Franco Voltini and Eugenio Reschini and Paolo Gerundini",
year = "2006",
doi = "10.1118/1.2210564",
language = "English",
volume = "33",
pages = "2860--2867",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients

AU - Canzi, Cristina

AU - Zito, Felicia

AU - Voltini, Franco

AU - Reschini, Eugenio

AU - Gerundini, Paolo

PY - 2006

Y1 - 2006

N2 - The aim of this study was to verify the capability of an MIRD formula-based dosimetric method to predict radioiodine kinetics (fraction of administered iodine transferred to the thyroid, U0, and effective clearance rate, λeff) and absorbed dose after oral therapeutic 131I administration. The method is based on 123I intravenous administration and five subsequent gamma camera measured uptake values determined separately on different structures within the thyroid. Another dosimetric method based on only the 123I 24-h uptake and a fixed λeff value was also considered. Eighty-nine hyperthyroid patients (10 with Graves' disease and 79 with autonomously functioning nodules) were studied and 132 thyroidal structures were evaluated. The mean time interval between dosimetry and therapy was 20±10d. Uptake values were measured at 2, 4, 24, 48, and 120 h during dosimetry and at 2, 4, 24, 48, 96, and 168 h during therapy. The value 0.125d-1 was chosen in the fixed-λeff method. The planned doses to the target ranged from 120 to 250 Gy depending on the type and severity of hyperthyroidism. The following significant correlations between therapeutic and dosimetric parameters were found: U0ther=0.88U0dos (r=0.97, peffther =1.01λeffdos (r=0.85, pestimated=0.85Dplanned (r=0.88, p0ther and U0dos ranged from -44 to 32% and between λeffther and λeffdos from -32 to 48%. U0ther was lower than U0dos in 74% of cases: this can be explained by the self-stunning effect of 131I therapeutic activity that produced a dose of about 20 Gy with a maximum dose rate of 0.6 Gy/h over the initial 24-48 h. The differences, ΔD, between the estimated and the planned doses ranged from -42% (-87 Gy) to 32% (59 Gy); in 73% of cases the difference was within ±35 Gy. Greater discrepancies were found with the fixed-λeff method, in which ΔD ranged from -69 to 95% (-202 to 88 Gy, respectively). In hyperthyroid patients, the five uptake value dosimetric method is able to predict with a good agreement the radioiodine kinetics and the dose after the therapeutic administration in about 73% of the analyzed thyroid structures. The fixed-λeff method is less reliable.

AB - The aim of this study was to verify the capability of an MIRD formula-based dosimetric method to predict radioiodine kinetics (fraction of administered iodine transferred to the thyroid, U0, and effective clearance rate, λeff) and absorbed dose after oral therapeutic 131I administration. The method is based on 123I intravenous administration and five subsequent gamma camera measured uptake values determined separately on different structures within the thyroid. Another dosimetric method based on only the 123I 24-h uptake and a fixed λeff value was also considered. Eighty-nine hyperthyroid patients (10 with Graves' disease and 79 with autonomously functioning nodules) were studied and 132 thyroidal structures were evaluated. The mean time interval between dosimetry and therapy was 20±10d. Uptake values were measured at 2, 4, 24, 48, and 120 h during dosimetry and at 2, 4, 24, 48, 96, and 168 h during therapy. The value 0.125d-1 was chosen in the fixed-λeff method. The planned doses to the target ranged from 120 to 250 Gy depending on the type and severity of hyperthyroidism. The following significant correlations between therapeutic and dosimetric parameters were found: U0ther=0.88U0dos (r=0.97, peffther =1.01λeffdos (r=0.85, pestimated=0.85Dplanned (r=0.88, p0ther and U0dos ranged from -44 to 32% and between λeffther and λeffdos from -32 to 48%. U0ther was lower than U0dos in 74% of cases: this can be explained by the self-stunning effect of 131I therapeutic activity that produced a dose of about 20 Gy with a maximum dose rate of 0.6 Gy/h over the initial 24-48 h. The differences, ΔD, between the estimated and the planned doses ranged from -42% (-87 Gy) to 32% (59 Gy); in 73% of cases the difference was within ±35 Gy. Greater discrepancies were found with the fixed-λeff method, in which ΔD ranged from -69 to 95% (-202 to 88 Gy, respectively). In hyperthyroid patients, the five uptake value dosimetric method is able to predict with a good agreement the radioiodine kinetics and the dose after the therapeutic administration in about 73% of the analyzed thyroid structures. The fixed-λeff method is less reliable.

KW - Dosimetry and therapy comparison

KW - Hyperthyroidism

KW - Radioiodine treatment

UR - http://www.scopus.com/inward/record.url?scp=33746638745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746638745&partnerID=8YFLogxK

U2 - 10.1118/1.2210564

DO - 10.1118/1.2210564

M3 - Article

C2 - 16964862

AN - SCOPUS:33746638745

VL - 33

SP - 2860

EP - 2867

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 8

ER -